INTS
INTENSITY THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$4.11
+5.93%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-3.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 20, 2026 | Donovan Daniel · director | A-Award | 5,500 | $4.90 |
| Jul 20, 2026 | DUBIN THOMAS I H · director | A-Award | 5,500 | $4.90 |
| Jul 20, 2026 | BENDER LEWIS H · director, officer: President and CEO | A-Award | 78,000 | $4.90 |
| Jul 20, 2026 | Talamo Joseph · officer: Chief Financial Officer | A-Award | 34,000 | $4.90 |
| Jul 20, 2026 | Wesolowski John M · officer: Principal Accounting Officer | A-Award | 11,000 | $4.90 |
| Jul 20, 2026 | Leahy Emer · director | A-Award | 5,500 | $4.90 |
| Jul 20, 2026 | GOLDBERG MARK A · director | A-Award | 5,500 | $4.90 |
| Jul 1, 2026 | Talamo Joseph · officer: Chief Financial Officer | A-Award | 1,093 | $3.48 |
| Jul 1, 2026 | Wesolowski John M · officer: Principal Accounting Officer | A-Award | 3,688 | $3.48 |
| Mar 30, 2026 | BENDER LEWIS H · director, officer: President and CEO | A-Award | 37,749 | $6.11 |
| Jan 5, 2026 | Wesolowski John M · officer: Principal Accounting Officer | A-Award | 8,918 | $0.26 |
| Jan 5, 2026 | Talamo Joseph · officer: Chief Financial Officer | A-Award | 14,482 | $0.26 |
| Jul 2, 2025 | Wesolowski John M · officer: Principal Accounting Officer | A-Award | 69,745 | $0.26 |
| Jul 2, 2025 | Talamo Joseph · officer: Chief Financial Officer | A-Award | 14,179 | $0.26 |
| May 6, 2025 | Donovan Daniel · director | A-Award | 50,000 | $0.57 |
| May 6, 2025 | GOLDBERG MARK A · director | A-Award | 50,000 | $0.57 |
| May 6, 2025 | Leahy Emer · director | A-Award | 50,000 | $0.57 |
| May 6, 2025 | Wesolowski John M · officer: Principal Accounting Officer | A-Award | 100,000 | $0.57 |
| May 6, 2025 | Talamo Joseph · officer: Chief Financial Officer | A-Award | 300,000 | $0.57 |
| May 6, 2025 | BENDER LEWIS H · director, 10 percent owner, officer: President and CEO | A-Award | 700,000 | $0.57 |
| May 6, 2025 | DUBIN THOMAS I H · director | A-Award | 50,000 | $0.57 |
| Oct 23, 2024 | Talamo Joseph · officer: Chief Financial Officer | A-Award | 427,379 | $3.44 |
| Oct 23, 2024 | Wesolowski John M · officer: Principal Accounting Officer | A-Award | 70,028 | $3.44 |
| Jun 7, 2024 | Wesolowski John M · officer: Principal Accounting Officer | M-Exempt | 1,000 | $4.00 |
| May 15, 2024 | DUBIN THOMAS I H · director | A-Award | 50,000 | $4.42 |
| Mar 7, 2024 | BENDER LEWIS H · director, 10 percent owner, officer: President and CEO | A-Award | 464,805 | $5.19 |
| Mar 7, 2024 | Donovan Daniel · director | A-Award | 50,000 | $5.19 |
| Mar 7, 2024 | Leahy Emer · director | A-Award | 50,000 | $5.19 |
| Mar 7, 2024 | Wesolowski John M · officer: See Remarks | A-Award | 25,000 | $5.19 |
| Mar 7, 2024 | GOLDBERG MARK A · director | A-Award | 50,000 | $5.19 |
Institutional positioning
13F filings over the trailing two quarters
New 9Increased 4Reduced 10Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| KMT WEALTH MANAGEMENT, LLC | New Position | 496,493 | Aug 5, 2026 |
| Kingsbury Capital Investment Advisors LLC | Increased | 496,493 | Aug 25, 2026 |
| Rothschild Wealth LLC | Increased | 26,723 | Aug 11, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 26,569 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 26,019 | May 15, 2026 |
| SAPIENT CAPITAL LLC | Reduced | 26,006 | Jun 22, 2026 |
| SAPIENT CAPITAL LLC | Unchanged | 26,006 | Jul 9, 2026 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | New Position | 25,000 | May 15, 2026 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | Unchanged | 25,000 | Aug 14, 2026 |
| SENTINUS, LLC | Reduced | 23,294 | May 6, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 22,787 | Aug 12, 2026 |
| FNY Investment Advisers, LLC | New Position | 22,000 | Jul 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 16,841 | May 15, 2026 |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | Reduced | 14,118 | Apr 21, 2026 |
| Mesirow Financial Investment Management, Inc. | Unchanged | 14,118 | Jul 22, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 20, 2026